| scholarly article | Q13442814 |
| P2093 | author name string | Feldmann E | |
| Morgenstern LB | |||
| Horwitz RI | |||
| Brott T | |||
| Broderick JP | |||
| Wilterdink JL | |||
| Viscoli CM | |||
| Brass LM | |||
| Kernan WN | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1826-1832 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Phenylpropanolamine and the risk of hemorrhagic stroke | |
| P478 | volume | 343 |
| Q81021313 | "Myocardial infarction" in adolescents: do we have the correct diagnosis? |
| Q47387087 | A Psychophysiological Mechanism Underlying Women's Weight-Management Goals: Women Desire and Strive for Greater Weight Loss Near Peak Fertility |
| Q35570030 | A benefit-risk assessment of sibutramine in the management of obesity |
| Q47218632 | APhA drug treatment protocols: comprehensive weight management in adults. |
| Q59795778 | AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study |
| Q37775254 | Acquired urinary incontinence in the bitch: update and perspectives from human medicine. Part 2: The urethral component, pathophysiology and medical treatment |
| Q28236003 | Acute myocardial infarction induced by ephedrine alkaloids |
| Q34789132 | Adverse drug reactions: current issues and strategies for prevention and management |
| Q37960526 | Adverse effects in women: implications for drug development and regulatory policies |
| Q52941486 | Adverse effects of observational studies when examining adverse outcomes of drugs: case-control studies with low prevalence of exposure. |
| Q37807698 | Alcohol, toxins, and medications as a cause of sleep dysfunction |
| Q35638706 | Allergy and the contemporary rhinologist |
| Q35087541 | Antiobesity drugs: current and future issues |
| Q30354242 | Antiobesity pharmacotherapy: new drugs and emerging targets |
| Q37073519 | Are non-prescription medications needed for weight control? |
| Q89620113 | Association Between D-dimer and Early Adverse Events in Patients With Acute Type A Aortic Dissection Undergoing Arch Replacement and the Frozen Elephant Trunk Implantation: A Retrospective Cohort Study |
| Q90751636 | Association of low-level blood lead with serum uric acid in U.S. adolescents: a cross-sectional study |
| Q36472245 | Blood pressure management in acute stroke: a long-standing debate. |
| Q24650293 | Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs) |
| Q64063943 | Cardiopulmonary bypass time is an independent risk factor for acute kidney injury in emergent thoracic aortic surgery: a retrospective cohort study |
| Q37413163 | Cardiovascular effects of noncardiovascular drugs |
| Q38126419 | Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies |
| Q29038770 | Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction |
| Q82535719 | Caudal nucleus haemorrhage due to dental anaesthesia |
| Q30388865 | Central and peripheral molecular targets for antiobesity pharmacotherapy |
| Q30775604 | Central nervous system vasculitis |
| Q57177981 | Centrally Acting Agents for Obesity: Past, Present, and Future |
| Q35036490 | Cerebrovascular complications of alcohol and sympathomimetic drug abuse |
| Q59740118 | Chapter 17 Stroke among women, ethnic groups, young adults, and children |
| Q36907362 | Childhood hemorrhagic stroke: an important but understudied problem |
| Q35859633 | Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused review |
| Q34112649 | Combination drugs for treating obesity |
| Q46090499 | Combined pharmacokinetic and urodynamic study of the effects of oral administration of phenylpropanolamine in female Beagle dogs |
| Q24634147 | Common cold |
| Q33446528 | Common cold. |
| Q47556269 | Comprehensive review of cardiovascular toxicity of drugs and related agents. |
| Q90606945 | Correlation between Myocardial Velocity Measured using Tissue Doppler Imaging in the Left Ventricular Lead-Implanted Segment and Response to Cardiac Resynchronization Therapy |
| Q35771615 | Current management of stress urinary incontinence |
| Q37119748 | Current pharmacologic treatment for orthostatic hypotension |
| Q35183760 | Current treatment for acute viral bronchiolitis in infants |
| Q35040372 | Diagnosis and treatment of ejaculatory dysfunction |
| Q36669199 | Dilemmas in the management of female stress incontinence: the role of pelvic floor muscle training |
| Q42737410 | Don't be so quick to ban medications |
| Q77298572 | Drug treatment of obesity |
| Q44295784 | Drug-induced hypertension |
| Q77512962 | Drug-induced vasculitis |
| Q44591404 | Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence |
| Q80297278 | Duloxetine: a new pharmacologic therapy for stress urinary incontinence |
| Q35207634 | Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence |
| Q64111071 | Effects of the blood urea nitrogen to creatinine ratio on haemorrhagic transformation in AIS patients with diabetes mellitus |
| Q34607745 | Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. |
| Q58942723 | Efficient 2-step biocatalytic strategies for the synthesis of all nor(pseudo)ephedrine isomers |
| Q47381676 | Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers |
| Q33993947 | Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994. |
| Q24201819 | Ephedrine for myasthenia gravis |
| Q24187268 | Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes |
| Q38717129 | Epidemiology of Obesity and Pharmacologic Treatment Options |
| Q30238502 | Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update |
| Q38758765 | Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles |
| Q43013499 | Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure |
| Q29540930 | Gastrointestinal Safety of an Extended-Release, Nondeformable, Oral Dosage Form (OROS??)* |
| Q28212356 | Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study |
| Q48288784 | Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure |
| Q34357826 | Hemorrhagic stroke after naphazoline exposition: case report |
| Q44884242 | High performance liquid chromatography with fluorescence detection for the determination of phenylpropanolamine in human plasma and rat's blood and brain microdialysates using DIB-Cl as a label |
| Q36941925 | Hypotheses, tests, methods, and innovation: the balancing act in research |
| Q34964119 | Infrequent causes of stroke |
| Q49025332 | International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis |
| Q82010316 | Intracerebral hemorrhage |
| Q34270481 | Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature |
| Q34257364 | Is there still a role for spontaneous reporting of adverse drug reactions? |
| Q44670458 | Issues related to monitoring the safety of over-the-counter (OTC) medicines |
| Q43593075 | It is important research, but why is it necessary? |
| Q36826600 | Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction |
| Q34417326 | Leukotriene receptor antagonists in the treatment of allergic rhinitis |
| Q97537832 | Low platelet count is a risk factor of postoperative pneumonia in patients with type A acute aortic dissection |
| Q34517464 | Management of hemorrhagic stroke |
| Q38121827 | Management of neurogenic orthostatic hypotension in patients with autonomic failure |
| Q34001059 | Manufactured uncertainty: protecting public health in the age of contested science and product defense |
| Q37587467 | Medical management of stress urinary incontinence: is there a future? |
| Q43120659 | Medication risk must be balanced with benefit, not fear |
| Q38249884 | Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit |
| Q35626453 | Molecular basis and genetic predisposition to intracranial aneurysm |
| Q42773956 | Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports |
| Q38290575 | Necroptosis-like Neuronal Cell Death Caused by Cellular Cholesterol Accumulation |
| Q30667363 | Neurologic manifestations of systemic vasculitis |
| Q34215606 | New OTC drugs and devices 2000: a selective review |
| Q30429816 | New advances in models and strategies for developing anti-obesity drugs |
| Q30353872 | New and emerging drug molecules against obesity. |
| Q34139090 | Nondrug interventions in hypertension prevention and control |
| Q90185367 | Nonlinear relationship between triglyceride/high-density lipoprotein cholesterol ratio and chronic kidney disease in US adults: a National Health and Nutrition Examination Survey investigation |
| Q47616467 | Noradrenergic Mechanisms Controlling Urethral Smooth and Striated Muscle Function in Urethral Continence Reflex in Rats |
| Q28344930 | Obesity |
| Q26828559 | Obesity pharmacotherapy: current perspectives and future directions |
| Q33827988 | Obesity pharmacotherapy: what is next? |
| Q46885883 | Obesity, diabetes, and associated risk factors |
| Q24198065 | Oestrogen therapy for urinary incontinence in post-menopausal women |
| Q34324746 | Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. |
| Q38057785 | Pathophysiology of urinary incontinence in murine models |
| Q33646392 | Patient presentation and physician management of upper respiratory tract infections: a retrospective review of over 5 million primary clinic consultations in Hong Kong |
| Q34435799 | Pediatric fatality following ingestion of dinitrophenol: postmortem identification of a "dietary supplement". |
| Q74376041 | Pharmacoepidemiology and drug safety |
| Q35022757 | Pharmacologic management of urinary incontinence in women |
| Q35556307 | Pharmacologic treatment of stress urinary incontinence: expectations for outcome |
| Q35574096 | Pharmacological agents used for the treatment of stress urinary incontinence in women |
| Q38335674 | Pharmacological treatment of pure stress urinary incontinence: a narrative review |
| Q45082550 | Pharmacologically-induced neurocatastrophes |
| Q21296814 | Pharmacotherapies for obesity: past, current, and future therapies |
| Q36468087 | Pharmacotherapy for childhood obesity: present and future prospects |
| Q77649542 | Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials |
| Q35826270 | Pharmacotherapy for stress urinary incontinence : present and future options |
| Q38219851 | Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents |
| Q82574887 | Pharmacotherapy of urinary incontinence |
| Q93500130 | Phenylpropanolamine and hemorrhagic stroke in women |
| Q35770633 | Phenylpropanolamine and the hemorrhagic stroke: A new search for the culprit |
| Q42347505 | Polypharmacy and medication adherence: small steps on a long road |
| Q43791051 | Position of the American Dietetic Association: weight management |
| Q37410222 | Postpartum Phenylpropanolamine-Induced Intracerebral Hemorrhage |
| Q98954598 | Predictive factors and nomogram to evaluate the risk of symptomatic intracerebral hemorrhage for stroke patients receiving thrombectomy |
| Q34572487 | Present and future: pharmacologic treatment of obesity |
| Q35760828 | Preventing a second stroke in the young |
| Q92442284 | Prolonged postoperative ileus in gastric surgery: Is there any difference between laparoscopic and open surgery? |
| Q46599362 | Pseudoephedrine-induced hemorrhage associated with a cerebral vascular malformation |
| Q24791301 | Quantifying errors without random sampling |
| Q35576535 | Recreational drugs and their neurological consequences |
| Q44093845 | Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America |
| Q97553883 | Related Factors Associated With Earthquake Inpatient Mortality |
| Q35622743 | Relationship between intracerebral hemorrhage and diabetes mellitus: a case-control study |
| Q57787186 | Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association |
| Q37359377 | Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns |
| Q37017163 | Risk of Intracerebral Hemorrhage after Emergency Department Discharges for Hypertension |
| Q30234520 | Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review. |
| Q44296362 | Risks associated with herbal slimming remedies |
| Q37114348 | Role of alpha2-adrenoceptors and glutamate mechanisms in the external urethral sphincter continence reflex in rats |
| Q36433990 | Safety of drug therapies used for weight loss and treatment of obesity |
| Q36299994 | Safety of obesity drugs |
| Q47153967 | Scientific Opinion on safety evaluation of Ephedra species for use in food |
| Q78021671 | Searching for alternatives |
| Q90353739 | Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study |
| Q34167229 | Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy |
| Q58695718 | Study to Probe Subsistence of Host-Guest Inclusion Complexes of α and β-Cyclodextrins with Biologically Potent Drugs for Safety Regulatory Dischargement |
| Q35749485 | Subarachnoid hemorrhage in Kashmir: Causes, risk factors, and outcome |
| Q43692911 | Sudden death attributed to ventricular arrhythmia induced by an over-the-counter cold medicine |
| Q37909132 | Supplemental studies for cardiovascular risk assessment in safety pharmacology: a critical overview |
| Q34626441 | Supplements and drugs used to enhance athletic performance |
| Q30401145 | Tackling obesity: new therapeutic agents for assisted weight loss. |
| Q39344867 | The attitude of physicians toward cold remedies for upper respiratory infection in infants and children: a questionnaire survey |
| Q36812582 | The clinical pharmacology of intranasal l-methamphetamine |
| Q80060632 | The development of single-isomer molecules: why and how |
| Q34128195 | The discovery and status of sibutramine as an anti-obesity drug |
| Q33997710 | The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial |
| Q44947045 | The epidemiology of overweight and obesity: public health crisis or moral panic? |
| Q33572547 | The media-medicine mix: quality concerns in medical reporting |
| Q35556318 | The role of estrogens in female lower urinary tract dysfunction |
| Q38160636 | The safety and efficacy of lorcaserin in the management of obesity |
| Q91967519 | The use of cIMT as a predictor of postoperative stroke in patients undergoing surgical repair of acute type a aortic dissection |
| Q22061940 | The vascular effects of trace amines and amphetamines |
| Q34255825 | Toxicity of weight loss agents |
| Q37114046 | Toxicology of the retina: advances in understanding the defence mechanisms and pathogenesis of drug- and light-induced retinopathy |
| Q87938525 | Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study |
| Q36815978 | Treating the metabolic syndrome. |
| Q80297265 | Treatment options for stress urinary incontinence |
| Q55420358 | Triglyceride to high-density lipoprotein cholesterol (HDL-C) ratio and arterial stiffness in Japanese population: a secondary analysis based on a cross-sectional study. |
| Q90264768 | Tumor deposit serves as a prognostic marker in gastric cancer: A propensity score-matched analysis comparing survival outcomes |
| Q34816583 | Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study |
| Q44039631 | Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study |
| Q36090438 | Weight loss is still an essential intervention in obesity and its complications: a review |
| Q35085370 | Weight management and current options in pharmacotherapy: orlistat and sibutramine |
| Q76384988 | [Twenty-first century sweets, a new toxicological threat?] |
Search more.